Clinical Trials Browser

Phase 3 × Terminated × Anthracyclines × Clear all

NCT05020665 2024-01-10

Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML

Phase 3 Terminated

15 enrolled 11 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00912444 2016-11-22

NATT

Phase 3 Terminated

Breast Neoplasms